TrialJAMA2021

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.

Silje Watterdal Syversen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.